Search

Your search keyword '"Ceravolo, M. D."' showing total 22 results
Start Over Author "Ceravolo, M. D."
22 results on '"Ceravolo, M. D."'

2. Genetic cardiac channelopathies and SIDS

Author

Bruno, L., Ceravolo, G., Ceravolo, M. D., Salpietro, A., Concolino, D., Sarro, R., Oreto, L., Tropeano, A., Viola, I., Chimenz, R., Cuppari, C., and Calabro, M. P.

Subjects
crib death, sudden infant death syndrome, cardiac channelopathies, SIDS, Humans, Infant, cardiac channelopathies, crib death, inherited arrhythmia syndromes, SIDS, sudden infant death syndrome, Arrhythmias, Cardiac, Channelopathies, Sudden Infant Death, inherited arrhythmia syndromes
Published
2020

3. PPHN and oxidative stress: a review of literature

Author

Chimenz, R., Cannavò, L., Gasbarro, A., Nascimben, F., Sestito, S., Rizzuti, L., Ceravolo, G., Ceravolo, M. D., Calabro, M. P., Romeo, C., and Gitto, E.

Subjects
Infant, Newborn, Humans, oxidative stress, melatonin, melatonin, oxidative stress, Persistent pulmonary hypertension, Persistent Fetal Circulation Syndrome, Antioxidants, Persistent pulmonary hypertension
Abstract

Persistent pulmonary hypertension of the neonate is a multifactorial condition characterized by maladaptive pulmonary vascular remodeling and abnormal contractile reactivity. This review evaluates the role of oxidative stress and antioxidant treatment on the persistent pulmonary hypertension of the neonate.

Published
2020

4. The heart in Anderson-Fabry disease

Author

Sestito, S., Roppa, K., Parisi, F., Moricca, M. T., Pensabene, L., Chimenz, R., Ceravolo, M. D., Ugo Cucinotta, Ceravolo, G., Calabro, M. P., Cuppari, C., Mondello, P., Musolino, D., Tallarico, V., and Concolino, D.

Subjects
Left Ventricular Hypertophy (LVH), Enzyme Replacement Therapy (ERT), α-galactosidase A, Cardiomyopathy, alpha-Galactosidase, Fabry Disease, Humans, Heart, Arrhythmias, Anderson-Fabry disease (AFD), valve disease, GLA gene, Anderson-Fabry disease (AFD), Arrhythmias, Cardiomyopathy, Enzyme Replacement Therapy (ERT), GLA gene, Left Ventricular Hypertophy (LVH), valve disease, α-galactosidase A
Published
2020

9. Cardiovascular complications in children with chronic kidney injury

Author

Meo, F., Salpietro, A., Ceravolo, G., Concolino, D., Sarro, R., Gitto, E., Viola, I., Sestito, S., Ugo Cucinotta, Giannitto, N., Cuppari, C., Corso, M., Ceravolo, M. D., Calabro, M. P., and Chimenz, R.

Subjects
cardiorenal syndrome, adverse cardiovascular events, cardiorenal syndrome, chronic kidney disease, CKD, CRS, adverse cardiovascular events, Heart Diseases, CKD, Humans, Child, Kidney, chronic kidney disease, CRS

11. COVID-19 ocular manifestation in children

Author

Ceravolo, I., Gitto, E., Sestito, S., Marseglia, L., Giuseppe Fabio Parisi, Borgia, F., Nicocia, G., Sarro, R., Salpietro, A., Manti, S., Cuppari, C., and Ceravolo, M. D.

13. Dilated cardiomyopathy in mucolipidosis type 2

Author

Carboni, E., Sestito, S., Lucente, M., Morrone, A., Zampini, L., Chimenz, R., Ceravolo, M. D., De Sarro, R., Ceravolo, G., Calabro, M. P., Parisi, F., Moricca, M. T., Pensabene, L., Musolino, D., and Concolino, D.

Subjects
dilated cardiomyopathy, Cardiomyopathy, Dilated, GNPTAB gene, Mucolipidoses, Mutation, mucolipidosis, Humans, Infant, Transferases (Other Substituted Phosphate Groups), Female, GNPTG gene, Child, dilated cardiomyopathy, GNPTAB gene, GNPTG gene, mucolipidosis
Abstract

Mucolipidosis II and III are lysosomal storage diseases caused by pathogenetic mutations in GNPTAB and GNPTG genes which cause an impaired activity of the lysosomal hydrolase N-acetylglucosamine- 1-phosphotransferase, a key enzyme in the synthesis of the mannose-6-phosphate targeting signals on lysosomal enzymes. Patients with MLII alpha/beta present coarse facial features, cessation of statural growth, important skeletal manifestations, impaired neuromotor development and cardiorespiratory involvement. All children appear to have cardiac involvement, but severe dilated cardiomyopathy is uncommon. In this report we describe the case of an 11-month-old girl who is affected by a MLII. Analysis of the GNPTAB gene identified at a heterozygous level the previously described gene variants c. 2693delA p(Lys898Serfs*13) and c. 2956CT p(Arg986Cys). Her main clinical features were coarse face with gingival hypertrophy, dysostosis multiplex, recurrent respiratory infection and an early onset of dilated cardiomyopathy, an uncommon feature for MLII. To our knowledge, dilated cardiomyopathy has been previously described in literature in only two cases of MLII and in one patient affected by MLIII.

14. Cardiovascular risk factors in childhood obesity.

Author

Amatruda M, Ceravolo MD, Ceravolo G, Cuppari C, Oreto L, Piraino B, Xerra F, Nicocia G, Salpietro C, and Calabrò MP

Subjects
Child, Humans, Overweight epidemiology, Risk Factors, Cardiovascular Diseases epidemiology, Cardiovascular Diseases etiology, Pediatric Obesity epidemiology
Abstract

Childhood obesity is the "disease of the century". This article reviews the early cardiovascular risk factors and the recommendations to prevent them in the overweight and obese children. A comprehensive search of published literature was carried out to identify all articles published on this topic in English and Italian from 1999 to 2020., (Copyright 2020 Biolife Sas. www.biolifesas.org.)

Published
2020

15. Genetic cardiac channelopathies and SIDS.

Author

Bruno L, Ceravolo G, Ceravolo MD, Salpietro A, Concolino D, De Sarro R, Oreto L, Tropeano A, Viola I, Chimenz R, Cuppari C, and Calabrò MP

Subjects
Arrhythmias, Cardiac, Humans, Infant, Channelopathies genetics, Sudden Infant Death genetics
Published
2020

16. Dilated cardiomyopathy in mucolipidosis type 2.

Author

Carboni E, Sestito S, Lucente M, Morrone A, Zampini L, Chimenz R, Ceravolo MD, De Sarro R, Ceravolo G, Calabrò MP, Parisi F, Moricca MT, Pensabene L, Musolino D, and Concolino D

Subjects
Child, Female, Humans, Infant, Mutation, Transferases (Other Substituted Phosphate Groups) genetics, Cardiomyopathy, Dilated complications, Cardiomyopathy, Dilated diagnostic imaging, Cardiomyopathy, Dilated genetics, Mucolipidoses complications, Mucolipidoses diagnosis, Mucolipidoses genetics
Abstract

Mucolipidosis II and III are lysosomal storage diseases caused by pathogenetic mutations in GNPTAB and GNPTG genes which cause an impaired activity of the lysosomal hydrolase N-acetylglucosamine- 1-phosphotransferase, a key enzyme in the synthesis of the mannose-6-phosphate targeting signals on lysosomal enzymes. Patients with MLII alpha/beta present coarse facial features, cessation of statural growth, important skeletal manifestations, impaired neuromotor development and cardiorespiratory involvement. All children appear to have cardiac involvement, but severe dilated cardiomyopathy is uncommon. In this report we describe the case of an 11-month-old girl who is affected by a MLII. Analysis of the GNPTAB gene identified at a heterozygous level the previously described gene variants c. 2693delA p(Lys898Serfs*13) and c. 2956C>T p(Arg986Cys). Her main clinical features were coarse face with gingival hypertrophy, dysostosis multiplex, recurrent respiratory infection and an early onset of dilated cardiomyopathy, an uncommon feature for MLII. To our knowledge, dilated cardiomyopathy has been previously described in literature in only two cases of MLII and in one patient affected by MLIII., (Copyright 2020 Biolife Sas. www.biolifesas.org.)

Published
2020

18. The heart in Anderson-Fabry disease.

Author

Sestito S, Roppa K, Parisi F, Moricca MT, Pensabene L, Chimenz R, Ceravolo MD, Cucinotta U, Ceravolo G, Calabrò MP, Cuppari C, Mondello P, Musolino D, Tallarico V, and Concolino D

Subjects
Heart, Humans, alpha-Galactosidase genetics, Fabry Disease genetics
Published
2020

20. PPHN and oxidative stress: a review of literature.

Author

Chimenz R, Cannavò L, Gasbarro A, Nascimben F, Sestito S, Rizzuti L, Ceravolo G, Ceravolo MD, Calabrò MP, Romeo C, and Gitto E

Subjects
Antioxidants, Humans, Infant, Newborn, Persistent Fetal Circulation Syndrome, Oxidative Stress
Abstract

Persistent pulmonary hypertension of the neonate is a multifactorial condition characterized by maladaptive pulmonary vascular remodeling and abnormal contractile reactivity. This review evaluates the role of oxidative stress and antioxidant treatment on the persistent pulmonary hypertension of the neonate., (Copyright 2020 Biolife Sas. www.biolifesas.org.)

Published
2020

21. Covid-19 and cardiac involvement in childhood: state of the art.

Author

Cuppari C, Ceravolo G, Ceravolo MD, Sestito S, Nicocia G, Chimenz R, Salpietro C, and Calabrò MP

Subjects
Adolescent, Betacoronavirus, COVID-19, Child, Coronavirus Infections physiopathology, Humans, Infant, Pandemics, Pneumonia, Viral physiopathology, Risk Factors, SARS-CoV-2, Coronavirus Infections complications, Heart Diseases virology, Pneumonia, Viral complications
Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in a cluster of patients in Wuhan, China, in December of 2019. Over the past few months, COVID-19 has rapidly spread worldwide becoming the first pandemic of the 21st century. COVID-19 results in mild symptoms in most infected children but can cause acute cardiac injury and death. In comparison to younger children, teenagers and infants are at higher risk for morbidity and mortality, with particular risk factors including pre-existing conditions like cardiovascular disease. Since this is an emerging infectious disease, there are limited data about the effects of this infection on patients especially in the pediatric population. We summarize here with the data on cardiovascular involvement in children and adolescents., (Copyright 2020 Biolife Sas. www.biolifesas.org.)

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results